豪达干酪中天然存在的抗高血压肽的分离与结构分析。

Isolation and structural analysis of antihypertensive peptides that exist naturally in Gouda cheese.

作者信息

Saito T, Nakamura T, Kitazawa H, Kawai Y, Itoh T

机构信息

Laboratory of Animal Products Chemistry, Graduate School of Agricultural Science, Tohoku University, Sendai, Japan.

出版信息

J Dairy Sci. 2000 Jul;83(7):1434-40. doi: 10.3168/jds.S0022-0302(00)75013-2.

Abstract

Seven kinds of ripened cheeses (8-mo-aged and 24-mo-aged Gouda, Emmental, Blue, Camembert, Edam, and Havarti) were homogenized with distilled water, and water-soluble peptides were prepared by C-18 hydrophobic chromatography. The inhibitory activity to angiotensin I-converting enzyme and decrease in the systolic blood pressure in spontaneously hypertensive rats were measured before and after oral administration of each peptide sample. The strongest depressive effect in the systolic blood pressure (-24.7 mm Hg) and intensive inhibitory activity to angiotensin I-converting enzyme (75.7%) were detected in the peptides from 8-mo-aged Gouda cheese. Four peptides were isolated by HPLC with reverse-phase and gel filtration modes. Their chemical structures and origins, clarified by combination analyses of protein sequencing, amino acid composition, and mass spectrometry, were as follows: peptide A, Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln [alpha(s1)-casein (CN), B-8P; f 1-9]; peptide B, Arg-Pro-Lys-His-Pro-Ile-Lys-His-Gln-Gly-Leu-Pro-Gln (alpha(s1)-CN, B-8P; f 1-13); peptide F, Tyr-Pro-Phe-Pro-Gly-Pro-Ile-Pro-Asn (beta-CN, A2-5P; f 60-68); and peptide G, Met-Pro-Phe-Pro-Lys-Tyr-Pro-Val-Gln-Pro-Phe (beta-CN, A2-5P; f 109-119). Peptides A and F, which were chemically synthesized, showed potent angiotensin I-converting enzyme inhibitory activity with little antihypertensive effects.

摘要

将七种成熟奶酪(8个月陈化和24个月陈化的荷兰干酪、埃门塔尔干酪、蓝纹奶酪、卡芒贝尔奶酪、伊顿奶酪和哈瓦蒂奶酪)与蒸馏水匀浆,通过C-18疏水色谱法制备水溶性肽。在口服每种肽样品前后,测量其对血管紧张素I转换酶的抑制活性以及对自发性高血压大鼠收缩压的降低情况。在8个月陈化的荷兰干酪中提取的肽对收缩压的抑制作用最强(-24.7 mmHg),对血管紧张素I转换酶的抑制活性也最强(75.7%)。通过反相和凝胶过滤模式的高效液相色谱法分离出四种肽。通过蛋白质测序、氨基酸组成和质谱分析相结合,阐明了它们的化学结构和来源,具体如下:肽A,精氨酸-脯氨酸-赖氨酸-组氨酸-脯氨酸-异亮氨酸-赖氨酸-组氨酸-谷氨酰胺[α(s1)-酪蛋白(CN),B-8P;f 1-9];肽B,精氨酸-脯氨酸-赖氨酸-组氨酸-脯氨酸-异亮氨酸-赖氨酸-组氨酸-谷氨酰胺-甘氨酸-亮氨酸-脯氨酸-谷氨酰胺(α(s1)-CN,B-8P;f 1-13);肽F,酪氨酸-脯氨酸-苯丙氨酸-脯氨酸-甘氨酸-脯氨酸-异亮氨酸-脯氨酸-天冬酰胺(β-CN,A2-5P;f 60-68);肽G,甲硫氨酸-脯氨酸-苯丙氨酸-脯氨酸-赖氨酸-酪氨酸-脯氨酸-缬氨酸-谷氨酰胺-脯氨酸-苯丙氨酸(β-CN,A2-5P;f 109-119)。化学合成的肽A和肽F显示出较强的血管紧张素I转换酶抑制活性,但降压作用较小。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索